1996
DOI: 10.1177/096032719601500702
|View full text |Cite
|
Sign up to set email alerts
|

Formation of DNA-adducts by selected sex steroids in rat liver

Abstract: 1 We are reporting investigations into the potential of the steroid hormones chlormadinone acetate (CMA), cyproterone acetate (CPA), ethinylestradiol (EE2) gestodene (GEST), megestrol acetate (MGA), norethis terone acetate (NET-Ac), estradiol (E 2), and progester one (P) to form DNA-adducts in rat liver in vivo. 2 Compound-related DNA-adduct spots were detected in male and female rat liver following CMA, CPA, and MGA using the 32 Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
7
0

Year Published

2001
2001
2009
2009

Publication Types

Select...
5
1
1

Relationship

0
7

Authors

Journals

citations
Cited by 17 publications
(7 citation statements)
references
References 11 publications
0
7
0
Order By: Relevance
“…CMA produces mammary tumors in dogs [32] and increases the incidence of mammary gland hyperplasia and mammary nodules [33]. It forms DNA adducts in rat and human hepatocytes in vitro [34][35][36] and also induces micronuclei in rat liver cells in vivo [20]. Antioxidants are known to reduce mutagenic potential of various mutagens in in vivo studies [37,38].…”
Section: Discussionmentioning
confidence: 99%
“…CMA produces mammary tumors in dogs [32] and increases the incidence of mammary gland hyperplasia and mammary nodules [33]. It forms DNA adducts in rat and human hepatocytes in vitro [34][35][36] and also induces micronuclei in rat liver cells in vivo [20]. Antioxidants are known to reduce mutagenic potential of various mutagens in in vivo studies [37,38].…”
Section: Discussionmentioning
confidence: 99%
“…This view is supported by the findings with two structural analogues of cyproterone acetate, chlormadinone acetate (CMA) and megestrol acetate (MGA) which also contain the 6,7-double bond. Both progestins were found to induce DNA adducts and unscheduled DNA synthesis in female rat and in human liver cells (Feser et al 1996;Martelli et al 1996b;Topinka et al 1995). In contrast, other sex steroids not possessing the 6,7-double bond, like gestodene, norethisterone acetate or the natural cyproterone acetate MiniReview analogue progesterone, were not able to form DNA adducts Feser et al 1996).…”
Section: Metabolic Activation To Dna Reactive Metabolitesmentioning
confidence: 97%
“…Horizontal arrows illustrate onset of various effects, vertical arrows amount of DNA adduct formation. a data from Werner et al (1995); b data from Topinka et al (1993); c data from Feser et al (1996); d data from Schulte-Hermann et al (1980); e data from Kasper & Mueller (1996); f data from Krebs et al (1998); g data from Martelli et al (1996a); h data from Deml et al (1993); i data from Schuppler & Günzel (1979).…”
Section: Risk Assessment On the Basis Of Preclinical Datamentioning
confidence: 99%
“…Both progestins were found to induce DNA adducts and unscheduled DNA synthesis in female rat and in human liver cells Martelli et al 1996b;Topinka et al 1995). In contrast, other sex steroids not possessing the 6,7-double bond, like gestodene, norethisterone acetate or the natural cyproterone acetate MiniReview analogue progesterone, were not able to form DNA adducts Feser et al 1996).…”
Section: Genotoxicity Studies In Human Liver Cellsmentioning
confidence: 99%
“…Horizontal arrows illustrate onset of various effects, vertical arrows amount of DNA adduct formation. a data from Werner et al (1995); b data from Topinka et al (1993); c data from Feser et al (1996); d data from Schulte-Hermann et al (1980); e data from Kasper & Mueller (1996); f data from Krebs et al (1998); g data from Martelli et al (1996a); h data from Deml et al (1993); i data from Schuppler & Günzel (1979). ic carcinogen generally implies that no safe dose can be defined since genotoxins, and among them in particular those which induce DNA adducts are assumed to operate by a non-thresholded mode of action. According to this view the quantitative differences in the dose-response relationship merely reflect differences in the detection limits of the various endpoints, e.g.…”
Section: Risk Assessment On the Basis Of Preclinical Datamentioning
confidence: 99%